The key changes brought by this regulatory act include:
- Mandatory clinical trials now apply to all devices, including those classified as risk classes 1 and 2a, which was not previously required.
- If a specific type of device is not included in the nomenclature of the EAEU, the reference authority is obliged to initiate its inclusion and notify the applicant.
- Terminology now aligns with international standards (IMDRF): the term "accidents" is replaced with "adverse events (incidents)."
- Wording has become clearer and more modern; for example, the terms "models (brands)," "by applicability," and "processing" have been clarified.
The EEC Decision No. 50, adopted on July 8, 2025, came into force on February 24, 2026.
EEC Decision "On Amendments to the Rules for the Registration and Expertise of the Safety, Quality, and Effectiveness of Medical Devices"
EEC Decision No. 50
Download document